Immunotherapy for Lung Cancer: PD-1 and Beyond, with Naiyer Rizvi Published 2015-11-13 Download video MP4 360p Recommendations 1:00:52 Immunotherapy for Lung Cancer: What Patients Need to Know, with Julie Brahmer 2:11:34 177 - The development of cancer immunotherapy and its promise for treating advanced cancers 1:32:16 An Answer to Cancer? Using the immune system to fight cancer -- Longwood Seminar 1:02:49 PD-L1/PD-1 Cancer Immunotherapy and New Targets - Gordon Freeman, PhD 1:08:25 Updates on Immunotherapy for Lung Cancer Patients 3:11:18 Robert Greene: A Process for Finding & Achieving Your Unique Purpose 28:49 Kratom Use and Dependence - Kate Neitzke, MD 55:10 CAR-T Cell Therapy: Now and in 2030 | Laboratory Medicine and Pathology in Individualized Medicine 3:46:40 273 ‒ Prostate health: common problems, cancer prevention, screening, treatment, and more 3:42:50 Dr. Paul Conti: How to Understand & Assess Your Mental Health | Huberman Lab Guest Series 27:32 Lung Cancer Staging 1:28:26 Cancer Metabolism: From molecules to medicine 2:29:54 #162 - Sarah Hallberg, D.O., M.S.: Treating metabolic disease, & a personal journey through cancer 2:46:55 Does Consciousness Extend Beyond Brains? The 2023 Holberg Debate, feat. Seth, Luhrmann, Sheldrake. 02:32 New report offers hope when it comes to lung cancer survival rates 3:54:38 Optogenetics: Illuminating the Path toward Causal Neuroscience 3:29:21 Dr. Robert Lustig: How Sugar & Processed Foods Impact Your Health 1:03:14 Lung Webinar with Hatim Husain, MD, UC San Diego Health 57:54 Latest Advancements in Pancreatic Cancer Treatments 03:46 Understanding Immunotherapy for Lung Cancer Similar videos 00:51 Dr. Rizvi on PD-L1 as a Biomarker for Immunotherapy Agents in Lung Cancer 07:11 Immunotherapy in the Frontline and as Part of Combinations for NSCLC 21:47 2/29/2016 - Session 1: Rizvi 05:43 Duration of Upfront Immunotherapy for NSCLC - O 42:48 Immunotherapy for Lung Cancer 06:53 Upfront PD-L1 Blockade in Newly Diagnosed NSCLC 20:48 Biologic basis of immunotherapy in lung cancer 50:51 Immunotherapy for Lung Cancer, with Glenn Dranoff 08:55 Treatment of Unresectable Locally Advanced NSCLC 46:35 The Role of Immunotherapy in Non Small Cell Lung Cancer NSCLC 55:22 Oncologist-to-Oncologist: How to Treat Your Patients with Immunotherapy 08:13 The Future of Lung Cancer Management 05:40 The Role of Mutation Burden as a Biomarker in NSCLC 20:05 What is the Role of Immunotherapy for Patients with Advanced NSCLC and a Driver Mutation? 05:10 Immuno-Oncology Combination Therapy in NSCLC 21:19 Lung Cancer Immunotherapy Q&A 1:50:50 Emerging Biomarkers, New Targets, and Rational Combinations in Immuno-Oncology More results